Q2 2026 orders rose to SEK 1,482m from SEK 1,425m (+6.3% currency-neutral), but net sales fell to SEK 1,362m from SEK 1,439m (-3.7% currency-neutral). Profitability weakened: adjusted EBITA declined to SEK 113.7m from SEK 158.6m (8.3% margin vs. 11.0%), and operating profit fell to SEK 96.9m from SEK 127.0m (7.1% margin vs. 8.8%). Overall, the mix of stronger demand with weaker sales/margins is a cautious signal.
The important signal is not the order growth itself; it is that the company is taking in backlog faster than it can monetize it, which usually means either lower-quality mix, delayed project conversion, or pricing pressure on renewals. That is typically a 1-2 quarter earnings lag story: the headline can look constructive while EBITA and cash conversion continue to deteriorate, especially if inventory and labor were scaled for sales that have not yet arrived.
For competitors, this is a mixed read. Higher-order-intake peers with stronger pricing discipline can still win share while this name absorbs margin compression, so the second-order beneficiary is the quality end of the industrial complex rather than the whole group. If the book is skewed to long-cycle or custom orders, suppliers may see volume later, but the near-term effect is usually working-capital drag and more pressure on guidance credibility.
The contrarian miss is that markets often anchor on order growth as an inflection, but the real tell is conversion rate and margin bridge. If the next print does not show a rebound in EBITA margin or a tighter revenue/order gap, the stock can de-rate further despite healthy demand headlines. What would falsify the bearish read is a clear gross-margin rebound, better execution on backlog, or management raising full-year margin assumptions within the next 1-2 quarters.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly negative
Sentiment Score
-0.25